Colgate Palmolive Co (CL)
NYSE · Price as of · Delayed Quote
- Analysts20
- Implied upside+11.5%
- Target range$87.00 to $110.00
- EPS expected$0.93 +2.2%
- A year ago$0.91
- Revenue expected$5.34B +4.1%
- Estimate range$0.89 to $0.96
Congress trades
| Date | Member | Action | Amount | |
|---|---|---|---|---|
| 2026-08-19 | Kevin Hern OK | Sale | $1,001 - $15,000 | |
| 2025-09-23 | Julie Johnson TX | Sale | $1,001 - $15,000 | |
| 2025-09-23 | Julie Johnson TX | Purchase | $1,001 - $15,000 | |
| 2025-04-08 | John Boozman AR | Purchase | $1,001 - $15,000 |
SEC filings
| Form | Filed | Description |
|---|---|---|
| 4 | August 26, 2026 | View on EDGAR |
| 144 | August 24, 2026 | View on EDGAR |
| 4 | August 7, 2026 | View on EDGAR |
| 144 | August 6, 2026 | View on EDGAR |
| 4 | August 6, 2026 | View on EDGAR |
| 144 | August 5, 2026 | View on EDGAR |
| 144 | August 4, 2026 | View on EDGAR |
| 144 | August 4, 2026 | View on EDGAR |
Articles that mention Colgate Palmolive without it being the main subject.
Frequently asked questions
When does CL report earnings?
Colgate Palmolive Co (CL) is scheduled to report quarterly results on October 30, 2026, before the open. The 17-analyst consensus is $0.93 per share on revenue of $5.34B for the quarter ending September 30, 2026, against $0.91 and $5.13B a year earlier. It has beaten the consensus EPS estimate in all four of the last four quarters.
What do analysts expect for CL?
20 analysts cover Colgate Palmolive Co (CL). No consensus rating has been published. The average price target is $98.95, in a range of $87.00 to $110.00.
Are insiders buying or selling CL?
We have no qualifying Form 4 insider purchases or sales on record for Colgate Palmolive Co (CL). Sales are only tracked above a dollar threshold, so small routine trades may not appear.
Where can I see CL SEC filings?
Recent filings are listed on this page, newest first. The latest is a 4 filed August 26, 2026.